Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs Ltd. (DLPL) has announced an earnings conference call for investors and analysts scheduled on Thursday, July 31, 2025, at 4:30 PM IST to discuss its Q1 FY26 financial and operating performance. The Q1 FY26 results will be announced on the same day before the call. The call will be led by Executive Chairman (Hony) Brig. Dr. Arvind Lal, CEO Mr. Shankha Banerjee, and Group CFO & CEO – International Business Mr. Ved Prakash Goel. Following management's discussion, participants will get an opportunity to ask questions. International dial-in numbers are available for participants from the USA, UK, Singapore, and Hong Kong. The company is one of India's leading diagnostic services providers with 298 clinical labs, 6,607 patient service centers, and 12,365 pick-up points as of March 31, 2025.
This is a routine regulatory intimation ahead of quarterly results and does not change the business outlook by itself. Investors should watch the Q1 FY26 numbers and management commentary on July 31 for any updates on growth, margins, and expansion plans.